Found 28 matching trials
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients PHASE3 The purpose of this study is to compare a standard chemotherapy regimen of ...
Show More Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Learn More & Join Trial
Carfilzomib/Cyclophosphamide/Dexamethasone with Maintenance Carfilzomib in Multiple Myeloma PHASE2 The Cardamon trial is a phase 2 trial using the standard chemotherapy drugs...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects PHASE1 The primary objective was to determine the maximum tolerated dose of carfil...
Show More Location
California Cancer Associates for Research and Excellence
Learn More & Join Trial
Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd) PHASE1 This protocol is a phase I/II multicenter study designed to assess the safe...
Show More Location
Fondazione EMN Italy Onlus
Learn More & Join Trial
2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy PHASE2 This study will assess whether adding one of the newest multiple myeloma th...
Show More Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Learn More & Join Trial
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma PHASE3 The goal of this study (iMMagine-3) is to compare the study drug, anitocabt...
Show More Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients PHASE2 The purpose of this study is to determine whether the association of Carfil...
Show More Location
IRCCS CROB UOC di Ematologia e trapianto cellule staminali Ospedale Oncologico Regionale
Learn More & Join Trial
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2) PHASE3 The purpose of this study is to compare the efficacy and safety of arlo-cel...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
A Study of Carfilzomib vs Best Supportive Care in Subjects With Relapsed and Refractory Multiple Myeloma PHASE3 This is a Phase 3, randomized, open-label, multicenter study comparing two ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia PHASE1 The purpose of Phase 1b of this study is to:
* Asses the safety, tolerabil...
Show More Location
University of California San Francisco Benioff Childrens Hospital Oakland
Learn More & Join Trial